Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - SHORT-TERM INVESTMENTS
Short-term Investments HALO - Halozyme Therapeutics, Inc.
480 M
LAST VALUE
93.24%
2 YEAR CAGR
9.79%
5 YEAR CAGR
20.53%
10 YEAR CAGR